First Detection of Resistance Genes Encoding Extended Spectrum Beta-Lactamase Producing Escherichia coli at Lome, Togo
Background: Extended Spectrum β-lactamases (ESBLs) are enzymes produced by some bacteria that ÅnÄ‚cÆŸvĂƚĞ oxyimino-cephalosporins, a class of β-lactam Ä‚nÆŸbÅŽƟcÆ family. They are mainly encoded by the β-lactamase gene families TEM, SHV and CTX-M. The Enterobacteriaceae expressing these genes, in ƉĂrÆŸcƵůĂr Escherichia coli are widely expanded in the world with ÄšÅīĞrÄžnÆš prevalence rate from one region to another. The ŽbũĞcÆŸvÄž of this study, carried out from strains isolated at the NĂƟŽnĂů /nÆÆŸÆšÆµÆšÄž of Hygiene (INH) in Togo, was to (i) detect and characterize the genes involving in the ƉrŽĚƵcƟŽn of β-lactamase among E. coli strains and (ii) evaluate their prevalence. Methodology: From May 2013 to July 2015, 91 E. coli strains resistant to third ÅÄžnÄžrĂƟŽn cephalosporins (C3G) were collected from several specimens and analyzed for the ĚĞƚĞcƟŽn of β-lactamase resistance genes, blaTEM, blaSHV and blaCTX-M by simplex and mƵůƟƉůĞx PCR. Results: The E. coli strains resistant at least to one third ÅÄžnÄžrĂƟŽn cephalosporin, were isolated from urine 58/91 (63.74%), vaginal samples 17/91 (17.68%), wound swabs 7/91 (7.69%), 4/91 semen samples (4.40%), urethral cƵrĞƩĂÅÄž CU 2/91 (2.20%), sputum 1/91 (1.1%), stool 1/91 (1.1%) and joint ŇƵÅÄš 1/91 (1.1%). Resistance to third ÅÄžnÄžrĂƟŽn cephalosporins was associated with a resistance to quinolone (96.67%), trimethoprim/sulfamethoxazole (94.44%), gentamicin (75.82%) and chloramphenicol (59.09%). ESBL genes were present in all E. coli strains with the following ƉrŽƉŽrƟŽnÆÍ— TEM/CTX-M1 52/91 (57.14%), TEM/SHV/CTX-M1 19/91 (20.88%), CTX-M 18/91 (19.78%), TEM 1/91 (1.10%) and TEM/SHV 1/91 (1.10%). Conclusion: The presence of ESBL producing E. coli is a reality in Togo and their wide ÄšÅÆÆÄžmÅnĂƟŽn compromises the treatment of classical ÅnĨĞcƟŽnÆ such as urinary tract ÅnĨĞcƟŽnÍ• bacterial pneumonia, sepsis or mÄžnÅnÅÅÆŸÆÍ˜ The Ä‚cqÆµÅÆÅÆŸÅ½n of molecular data on bacterial resistance to Ä‚nÆŸbÅŽƟcÆ is necessary for bĞƩĞr ƚŚĞrĂƉĞƵƟc management of these ÅnĨĞcƟŽnÆÍ˜ This is a Ä®rÆÆš ĚĞƚĞrmÅnĂƟŽn of the βlactamase genes in Togo.